Today’s medicines can cost hundreds of thousands of dollars a year. The story of how two companies set prices for their costly new drugs suggests that the way we determine the value of such treatments will help decide the future of our health-care system.
Google’s ambitious book-scanning program is foundering in the courts. Now a Harvard-led group is launching its own sweeping effort to put our literary heritage online. Will the Ivy League succeed where Silicon Valley failed?